Objectives : This study was designed to establish the incidence, impact, and predictors of
post-transcatheter aortic valve replacement (TAVR) aortic regurgitation (AR). Background : AR …

… Samir Kapadia … Procedural anticoagulation to reach a target activated clotting time over
250 s is … Murphy CJ, Pasupati S. and Webb JG : "Hemolysis after transcatheter balloon-…

Ventricular septal rupture (VSR) after acute myocardial infarction is increasingly rare in the
percutaneous coronary intervention era but mortality remains high. Prompt diagnosis is key …

Background The use of transcatheter aortic-valve replacement has been shown to reduce
mortality among high-risk patients with aortic stenosis who are not candidates for surgical …

Background Previous trials have shown that among high-risk patients with aortic stenosis,
survival rates are similar with transcatheter aortic-valve replacement (TAVR) and surgical …

Background Among patients with aortic stenosis who are at intermediate or high risk for
death with surgery, major outcomes are similar with transcatheter aortic-valve replacement (…

… We find that Republican members of Congress who supported President Trump’s “stop the
… between condoning or opposing Donald Trump’s efforts to overturn the 2020 presidential …

Background Among patients with heart failure who have mitral regurgitation due to left ventricular
dysfunction, the prognosis is poor. Transcatheter mitral-valve repair may improve their …

Background The Placement of Aortic Transcatheter Valves (PARTNER) trial showed that
mortality at 1 year, 2 years, and 3 years is much the same with transcatheter aortic valve …

Background Transcatheter aortic-valve replacement (TAVR) is the recommended therapy
for patients with severe aortic stenosis who are not suitable candidates for surgery. The …